
Etiotropic therapy of the new coronavirus infection. Expectations and realities. Part 2
Author(s) -
Olga Yu. Kuznetsova
Publication year - 2022
Publication title -
rossijskij semejnyj vrač
Language(s) - English
Resource type - Journals
eISSN - 2713-2331
pISSN - 2072-1668
DOI - 10.17816/rfd108485
Subject(s) - ritonavir , coronavirus , medicine , drug , placebo , clinical trial , monoclonal antibody , virology , intensive care medicine , covid-19 , pharmacotherapy , randomized controlled trial , protease inhibitor (pharmacology) , drug trial , immunology , viral load , pharmacology , virus , alternative medicine , antibody , pathology , disease , antiretroviral therapy , infectious disease (medical specialty)